Researchers developed a humanized mouse model that better predicts how antibody drugs interact with the immune system. The ...

GV Safety Assessment Platform (GVSAP), an integrated preclinical R&D enabler within the GVRP portfolio, today announced an expansion of its strategic collaboration with Biocytogen (SSE: 688796; HKEX: ...

We came across a bullish thesis on Twist Bioscience Corporation on Clinical Catalysts’s Substack. In this article, we will ...

Zuckerberg and Chan’s philanthropy is restructuring to prioritize A.I.-powered biomedical research over social programs.

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

An international research consortium, led by scientists at VIB and UGent, has developed a new platform that could change how antibody medicines are tested and brought to patients. The work, published ...

Read about the backgrounds and research interests of team members in Dr. Grinberg's Neurodegeneration and Sleep Pathology Lab at Mayo Clinic.

Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing ...

Engineered BiTE molecule draws T cells to eliminate FAP+ modulated smooth muscle cells, reducing plaque burden across mouse atherosclerosis models.

The Trump administration first instituted a ban ending all human fetal tissue research at NIH in 2019, but it was reversed by the Biden administration in 2021. The current ban stops NIH funds from ...